Tab Reaches $300 Million Valuation With AI Assistant That Texts, Calls and Pays on Users’ Behalf
Tab has reportedly reached a $300 million valuation with an AI-powered personal assistant designed to handle everyday tasks, including sending text messages, making phone calls and processing payments on behalf of users.
The development highlights the growing shift in artificial intelligence from conversational chatbots to autonomous agents capable of taking real-world actions. Instead of simply answering questions or offering recommendations, these systems aim to complete tasks with minimal human intervention.
Tab’s approach combines communication and payment capabilities, potentially allowing users to delegate routine responsibilities such as contacting service providers, coordinating appointments and settling bills. By managing multiple steps through a single assistant, the technology could reduce the time and effort required to handle everyday activities.
However, giving AI systems the authority to communicate and spend money also raises important questions about privacy, security and accountability. Safeguards such as transaction approvals, spending limits and transparent activity records will be essential to prevent unauthorised payments and communication errors.
The reported valuation reflects growing investor interest in AI agents that deliver practical utility beyond traditional chat interfaces. As competition intensifies, reliability and user trust will be critical to commercial success.
Tab’s progress underscores a broader industry ambition: creating AI assistants that do not merely suggest what users should do, but actually help them get it done.
DeepMind Spinout Isomorphic Labs Eyes $40 Billion Valuation After $2.1 Billion Funding Round
Isomorphic Labs, the artificial intelligence-driven drug discovery company spun out of Google DeepMind, is reportedly targeting a valuation of $40 billion less than five months after raising $2.1 billion. The potential valuation reflects growing investor confidence in AI-powered biotechnology and its ability to transform pharmaceutical research.
Founded in 2021, Isomorphic Labs applies advanced AI technologies to accelerate drug discovery and help researchers understand complex biological systems. Its approach aims to identify promising drug candidates, predict molecular interactions and reduce the time required to develop potential treatments.
Traditional drug discovery often involves lengthy research cycles and significant financial investment. By using AI models to analyse biological data and support molecular design, Isomorphic Labs aims to make parts of this process faster and more efficient.
The reported valuation would mark a substantial increase in the company’s implied market worth following its recent funding round. However, discussions around a potential valuation do not guarantee that a deal will be completed.
The company’s ambitions come amid growing interest in applying AI to scientific research, particularly in the pharmaceutical sector. Despite the promise, AI-generated drug candidates must still undergo extensive testing, clinical trials and regulatory approval.
If achieved, the reported valuation would position Isomorphic Labs among the most highly valued AI-focused biotechnology companies, highlighting the expanding intersection of artificial intelligence and medicine.
Sussex Spinout Universal Quantum Raises $100 Million+ as UK Quantum Funding Race Heats Up
Universal Quantum, a quantum computing company spun out of the University of Sussex, has reportedly raised more than $100 million in Series A funding as competition in the UK’s quantum technology sector intensifies.
The funding will support the company’s efforts to develop scalable quantum computers capable of solving complex problems that conventional computing systems struggle to address. Universal Quantum is developing technology designed to connect individual quantum processing modules, potentially enabling the construction of larger and more powerful quantum computers.
Quantum computing uses the principles of quantum mechanics to process information differently from traditional computers. The technology could eventually support breakthroughs in drug discovery, materials science, financial modelling and advanced scientific research.
The latest funding highlights growing investor interest in commercialising quantum technologies. Governments and private companies are increasingly investing in the sector, viewing it as a potential source of long-term technological and economic growth.
The United Kingdom has been strengthening its position in quantum research, with startups competing to turn scientific breakthroughs into commercially viable products. Funding rounds such as Universal Quantum’s could help companies expand research, recruit specialised talent and advance hardware development.
However, quantum computing remains an emerging field, with major challenges involving error correction, reliability and scalability.
Universal Quantum’s reported Series A funding marks an important step in its development as the company works towards building practical quantum computing systems for future industrial and scientific applications.
Endeavor Catalyst Closes Oversubscribed $320 Million Fund V, Backing AI and Space Technology Growth
Endeavor Catalyst, an investment platform supporting high-growth entrepreneurs, has closed its fifth fund at $320 million after attracting commitments exceeding its fundraising target. The development highlights continued investor interest in technology startups with global expansion potential.
The investment platform has backed companies including ElevenLabs, an artificial intelligence-powered voice technology company, and ICEYE, a satellite technology firm specialising in radar-based Earth observation.
Through its investment activities, Endeavor Catalyst supports entrepreneurs building businesses across international markets. Its approach focuses on helping founders access capital and scale companies with the potential to make a significant commercial impact.
The closure of Fund V comes amid growing interest in artificial intelligence, space technology and other innovation-driven industries. Companies operating in these sectors are developing solutions for applications ranging from AI-generated audio and digital content to satellite monitoring and disaster management.
An oversubscribed fund indicates that investor commitments exceeded the amount initially sought, reflecting strong demand for participation. However, fundraising success does not guarantee investment returns, particularly in rapidly evolving technology markets.
The new fund is expected to strengthen Endeavor Catalyst’s ability to support ambitious entrepreneurs as they expand operations, enter new markets and develop innovative products.
The $320 million fund closure underscores the continuing role of venture capital in helping emerging technology companies secure resources and pursue international growth.
